Republican · U.S. House · North Carolina, District 5
Latest filing Dec 12, 2017
Yes. Virginia Foxx disclosed 2 purchases and 2 sales of Merck (MRK) stock between Oct 13, 2014 and Nov 21, 2017, in STOCK Act reports. Added together, the disclosed purchases come to $16K-$65K and the disclosed sales to $65K-$150K.
Yes. Virginia Foxx disclosed 2 purchases and 2 sales of Merck (MRK) stock between Oct 13, 2014 and Nov 21, 2017, in STOCK Act reports. Added together, the disclosed purchases come to $16K-$65K and the disclosed sales to $65K-$150K.
How big were Virginia Foxx's Merck trades?
STOCK Act reports give a range for each trade, such as $15K-$50K, never an exact amount. Added together, the disclosed purchases come to $16K-$65K and the disclosed sales to $65K-$150K.
Did Virginia Foxx make these Merck trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does Virginia Foxx still own Merck stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did Virginia Foxx report these trades?
The latest filing is dated Dec 12, 2017. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.
Loading